Shukra Pharmaceuticals Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Consolidate Quarterly Results

Dec'25

Sep'25

Dec'24

Net Sales

39.13

5.88

10.58

Other Operating Income

0.00

Total Operating income

39.13

5.88

10.58

Raw Material Cost

3.20

10.81

3.78

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

3.93

-8.80

0.18

Employee Cost

2.65

2.19

1.55

Power Cost

0.00

Manufacturing Expenses

0.00

-0.01

Selling and Distribution Expenses

0.00

Other Expenses

2.22

2.11

1.14

Total Expenditure (Excl Depreciation)

12.00

6.30

6.64

Operating Profit (PBDIT) excl Other Income

27.13

-0.42

3.94

Other Income

0.82

1.71

1.01

Operating Profit (PBDIT)

27.95

1.29

4.95

Interest

0.28

0.29

0.15

Exceptional Items

0.00

Gross Profit (PBDT)

27.67

1.00

4.80

Depreciation

0.84

0.81

0.70

Profit Before Tax

26.83

0.20

4.09

Tax

6.47

-2.18

0.93

Provisions and contingencies

0.00

Profit After Tax

20.36

2.38

3.16

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

20.36

2.38

3.16

Share in Profit of Associates

0.00

Minority Interest

0.00

Other related items

0.00

Consolidated Net Profit

20.36

2.38

3.16

Equity Capital

43.79

Face Value

1.0

Reserves

0.00

Earnings per share (EPS)

0.46

0.05

0.01

Diluted Earnings per share

0.47

0.05

0.07

Operating Profit Margin (Excl OI)

69.33%

-7.14%

37.24%

Gross Profit Margin

70.71%

17.01%

45.37%

PAT Margin

52.03%

40.48%

29.87%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Dec 2025 is 565.48% vs 9.09% in Sep 2025

Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is 755.46% vs 131.07% in Sep 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 6,559.52% vs -131.82% in Sep 2025

Interest

QoQ Growth in quarter ended Dec 2025 is -3.45% vs 7.41% in Sep 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of Shukra Pharma. With

Select Peers

Figures in Cr

Consolidate Quarterly Results

Change(INR)

Change(%)

Net Sales

39.13

244.40

-205.27

-83.99%

Other Operating Income

0.00

Total Operating income

39.13

244.40

-205.27

-83.99%

Raw Material Cost

3.20

95.37

-92.17

-96.64%

Purchase of Finished goods

0.00

2.26

-2.26

-100.00%

(Increase) / Decrease In Stocks

3.93

20.42

-16.49

-80.75%

Employee Cost

2.65

33.35

-30.70

-92.05%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

2.22

61.24

-59.02

-96.37%

Total Expenditure (Excl Depreciation)

12.00

212.64

-200.64

-94.36%

Operating Profit (PBDIT) excl Other Income

27.13

31.76

-4.63

-14.58%

Other Income

0.82

20.18

-19.36

-95.94%

Operating Profit (PBDIT)

27.95

51.94

-23.99

-46.19%

Interest

0.28

3.04

-2.76

-90.79%

Exceptional Items

0.00

Gross Profit (PBDT)

27.67

48.90

-21.23

-43.42%

Depreciation

0.84

8.26

-7.42

-89.83%

Profit Before Tax

26.83

40.63

-13.80

-33.97%

Tax

6.47

12.04

-5.57

-46.26%

Provisions and contingencies

0.00

Profit After Tax

20.36

28.59

-8.23

-28.79%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

20.36

28.59

-8.23

-28.79%

Share in Profit of Associates

0.00

Minority Interest

0.00

1.34

-1.34

-100.00%

Other related items

0.00

Consolidated Net Profit

20.36

27.25

-6.89

-25.28%

Equity Capital

43.79

10.56

33.23

314.68%

Face Value

1.00

0.00

Reserves

0.00

Earnings per share (EPS)

0.46

2.58

-2.12

-82.17%

Diluted Earnings per share

0.47

2.54

-2.07

-81.50%

Operating Profit Margin (Excl OI)

69.33%

13.00%

0.00

56.33%

Gross Profit Margin

70.71%

20.01%

0.00

50.70%

PAT Margin

52.03%

11.70%

0.00

40.33%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 39.13 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 565.48% vs 9.09% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 269.85% vs -43.99% in Dec 2024

Quarterly - Standalone Net Profit

Standalone Net Profit 20.36 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 755.46% vs 131.07% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 544.30% vs -66.45% in Dec 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 27.13 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 6,559.52% vs -131.82% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 588.58% vs -58.70% in Dec 2024

Quarterly - Interest

Interest 0.28 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -3.45% vs 7.41% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 86.67% vs 114.29% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 69.33%

in Dec 2025

Figures in %

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024